Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)

Home
002898.SZ
Financials

12.44 (CNY) • At close October 26, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3
Revenue Numbers are in millions	61.466	85.452	69.484	85.249	68.595	77.355	79.428	71.357	61.471	69.156	62.209	61.653	56.394	60.737	68.294	-6.16	38.409	56.112	32.324	78.474	42.666	106.272	66.055	110.805	96.145	138.802	90.521	114.752	106.457	99.556	43.453	78.057	53.682
Cost of Revenue Numbers are in millions	36.299	45.468	41.874	56.6	36.897	36.812	36.852	46.172	27.415	24.755	24.598	24.744	19.212	17.3	22.208	14.335	8.424	14.936	5.613	24.472	12.495	14.702	23.891	46.875	45.301	50.432	46.2	84.95	22.971	33.692	18.19	36.073	23.088
Gross Profit Numbers are in millions	25.168	39.984	27.61	28.649	31.697	40.544	42.576	25.185	34.057	44.4	37.611	36.909	37.182	43.437	46.087	-20.495	29.985	41.176	26.711	54.002	30.171	91.571	42.165	63.93	50.844	88.37	44.321	29.801	83.486	65.864	25.263	41.984	30.594
Gross Profit Ratio Numbers are in millions	0.409	0.468	0.397	0.336	0.462	0.524	0.536	0.353	0.554	0.642	0.605	0.599	0.659	0.715	0.675	3.327	0.781	0.734	0.826	0.688	0.707	0.862	0.638	0.577	0.529	0.637	0.49	0.26	0.784	0.662	0.581	0.538	0.57
Reseach & Development Expenses Numbers are in millions	7.222	4.982	5.345	5.695	6.694	7.863	7.277	5.758	6.031	7.57	4.143	6.423	6.041	3.918	5.03	9.441	6.505	5.096	4.63	9.309	3.416	2.43	2.426	8.567	2.922	0.059	4.69	6.082	4.812	12.954	0	20.279	0
General & Administrative Expenses Numbers are in millions	0	-3.789	11.152	-19.146	28.992	-3.317	10.931	-15.27	22.963	-2.705	8.726	-12.062	20.702	-2.808	7.883	-11.47	10.068	-4.271	10.89	-19.104	9.968	-3.898	9.952	-13.528	7.07	-7.745	13.55	-25.248	12.88	-6.008	12.202	-20.477	12.905
Selling & Marketing Expenses Numbers are in millions	0	23.581	5.454	4.008	10.174	22.037	20.931	34.884	15.127	26.466	22.227	40.32	17.766	27.267	28.113	11.091	23.545	27.674	12.243	34.777	17.921	57.208	24.745	33.383	24.638	44.409	23.604	-3.91	48.461	23.049	5.036	5.887	5.162
SG&A Numbers are in millions	22.198	32.342	16.606	-15.138	39.166	18.72	31.862	19.613	38.09	23.761	30.952	28.258	38.468	24.459	35.996	-0.379	33.613	23.403	23.133	15.673	27.889	53.31	34.697	19.856	31.708	36.664	37.154	-29.159	61.341	17.041	17.238	-14.59	18.067
Other Expenses Numbers are in millions	0.93	-1.128	-0.04	0.234	-4.52	4.076	0.299	26.33	-11.345	13.241	1.067	6.75	-2.063	1.986	-0.131	32.848	-0.024	0.441	-1.541	0.278	-0.142	-0.388	-0.011	-2.549	0.022	-2.313	1.202	-7.241	1.78	3.577	-0.008	-1.624	2.186
Operating Expenses Numbers are in millions	28.49	38.451	22.406	15.737	32.884	41.759	39.439	51.701	32.776	44.572	36.162	60.314	33.471	40.719	42.048	34.541	40.209	47.106	27.482	42.416	32.675	71.357	38.098	48.107	35.927	52.14	37.995	6.62	62.867	39.901	18.121	23.644	18.618
Operating Income Numbers are in millions	-3.322	1.533	2.177	11.165	3.821	3.577	4.004	-33.143	1.281	5.919	-0.512	-29.825	4.115	8.405	3.72	-27.018	-9.717	-7.038	-3.213	10.902	-2.848	20.733	3.703	14.392	15.808	34.876	5.116	25.384	18.671	27.869	4.883	18.323	13.201
Operating Income Ratio Numbers are in millions	-0.054	0.018	0.031	0.131	0.056	0.046	0.05	-0.464	0.021	0.086	-0.008	-0.484	0.073	0.138	0.054	4.386	-0.253	-0.125	-0.099	0.139	-0.067	0.195	0.056	0.13	0.164	0.251	0.057	0.221	0.175	0.28	0.112	0.235	0.246
Total Other Income Expenses Net Numbers are in millions	-2.038	0.032	-0.04	0.234	-0.292	-0.151	-0	-0.655	1.69	-6.713	0	0.024	-0.066	-0.011	-0.131	-0.716	-0.024	0.441	-1.541	0.278	-0.142	-0.388	-0.011	-0.337	0.022	0.178	-0.053	-5.771	1.78	3.543	-0.008	-0.087	2.186
Income Before Tax Numbers are in millions	-5.361	0.259	2.137	11.399	3.529	3.425	4.004	-33.798	2.971	-0.794	1.95	-29.801	4.048	8.394	3.589	-27.734	-9.741	-6.597	-4.754	11.18	-2.99	20.345	3.692	14.055	15.829	33.799	6.318	19.743	20.451	31.412	4.875	18.234	15.388
Income Before Tax Ratio Numbers are in millions	-0.087	0.003	0.031	0.134	0.051	0.044	0.05	-0.474	0.048	-0.011	0.031	-0.483	0.072	0.138	0.053	4.502	-0.254	-0.118	-0.147	0.142	-0.07	0.191	0.056	0.127	0.165	0.244	0.07	0.172	0.192	0.316	0.112	0.234	0.287
Income Tax Expense Numbers are in millions	0.097	0.119	0.513	6.189	2.192	3.635	0.806	5.212	2.325	-0.565	0.669	5.341	1.663	1.042	1.526	17.919	-1.385	-0.946	2.808	2.592	-1.663	3.269	0.545	0.491	2.975	4.925	0.706	2.17	6.052	0.217	3.536	2.458	2.279
Net Income Numbers are in millions	-5.458	0.141	1.624	5.209	1.337	-0.21	3.197	-39.009	0.645	-0.229	1.281	-35.142	2.385	7.352	2.064	-45.653	-8.356	-5.65	-7.562	8.587	-1.327	17.076	3.147	13.564	12.854	28.874	5.612	17.573	14.399	31.195	1.338	15.776	13.109
Net Income Ratio Numbers are in millions	-0.089	0.002	0.023	0.061	0.019	-0.003	0.04	-0.547	0.01	-0.003	0.021	-0.57	0.042	0.121	0.03	7.411	-0.218	-0.101	-0.234	0.109	-0.031	0.161	0.048	0.122	0.134	0.208	0.062	0.153	0.135	0.313	0.031	0.202	0.244
EPS Numbers are in millions	-0.031	0.001	0.009	0.03	0.008	-0.001	0.018	-0.22	0.004	-0.001	0.007	-0.2	0.014	0.042	0.012	-0.26	-0.048	-0.032	-0.043	0.049	-0.008	0.094	0.017	0.077	0.073	0.16	0.032	0.1	0.082	0.24	0.01	0.12	0.1
EPS Diluted Numbers are in millions	-0.031	0.001	0.009	0.03	0.008	-0.001	0.018	-0.22	0.004	-0.001	0.007	-0.2	0.014	0.042	0.012	-0.26	-0.048	-0.032	-0.043	0.049	-0.008	0.094	0.017	0.077	0.073	0.16	0.032	0.1	0.082	0.24	0.01	0.12	0.1
EBITDA Numbers are in millions	-3.333	10.049	10.674	21.302	13.383	13.909	13.334	-21.776	11.769	6.668	12.439	-18.825	14.643	17.94	11.866	-21.841	-3.52	2.033	-3.668	17.094	1.024	25.241	7.622	14.014	15.843	35.894	8.872	22.8	22.497	27.339	7.142	18.34	11.976
EBITDA Ratio Numbers are in millions	-0.054	0.115	0.076	0.156	-0.08	0.042	0.036	-0.137	-0.085	0.096	0.028	-0.262	0.033	0.218	0.064	3.546	-0.263	-0.094	-0.077	0.166	-0.057	0.194	0.071	0.144	0.161	0.259	0.091	0.199	0.211	0.275	0.217	0.237	0.224

Sailong Pharmaceutical Group Co., Ltd.

SZSE:002898.SZ Add to watchlist

SZSE:002898.SZ